fda approval in ovarian cancer, priority reviews in nsclc, cll, and follicular lymphoma, and more
Published 6 years ago • 84 plays • Length 7:26
Download video MP4
Download video MP3
Similar videos
-
9:29
fda approvals in all and breast cancer, priority reviews in cml and follicular lymphoma, and more
-
7:39
fda approvals in all, ovarian cancer, priority review in ctcl, and snda submitted in rcc
-
9:08
fda approvals in cervical cancer, ovarian cancer, and cll, and more
-
9:25
fda approvals in large b-cell lymphoma and melanoma, priority reviews in cscc and nsclc, and more
-
7:19
fda approval in hcc, priority reviews in tnbc and ovarian cancer, snda in itp, and more
-
8:44
priority review in nsclc, label update in cll, delayed fda decision in lung cancer, and more
-
6:24
fda approval and priority review in ovarian cancer, end of part b payment model, and more
-
10:49
fda approvals in myeloma, nets, and of a biosimilar, priority review in ovarian cancer, and more
-
0:31
preview: fda approval and priority review in ovarian cancer, end of part b payment model, and more
-
9:40
fda approval in nsclc, priority reviews, and 2016 elcc highlights
-
7:28
fda approvals in pml, nsclc, and breast cancer, priority review in dlbcl, and more
-
9:10
fda approvals in cml and hodgkin lymphoma, priority review in crc, and more
-
9:41
fda approvals in follicular lymphoma and prostate cancer, biosimilar is granted approval, and more
-
7:39
fda approvals in follicular lymphoma and gi, lung nets, snda in prostate cancer, and more
-
9:54
fda approval in nsclc, priority review designation in sclc, crl to biosimilar, and more
-
9:27
fda approvals in rcc and cml, priority review designations in nsclc and rcc, and more
-
11:00
fda approval in her2 breast cancer, priority review in nsclc, and more
-
8:12
fda approvals in hcc, sclc, and nsclc, priority review in rare blood cancer, and more
-
13:43
fda approvals in ntrk fusion tumors, ros1 nsclc, and myelofibrosis, and more
Clip.africa.com - Privacy-policy